Lv1
74 积分 2025-10-11 加入
MET Alterations in Cancer and MET-Targeted Therapy: Detection Strategies, Treatment Efficacy, and Emerging Technologies
1个月前
已完结
Rearranged during transfection (RET) lung cancer – Update on targeted therapies
1个月前
已完结
AXL and c‐Met Dual‐Targeting in Non‐Small Cell Lung Cancer: A Review of Small‐Molecule Inhibitors and Their Structure–Activity Relationships
1个月前
已完结
Antibody–drug conjugates in lung cancer: current landscape and future perspectives
1个月前
已完结
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
1个月前
已完结
Lorlatinib in Tyrosine Kinase Inhibitor−Naive Advanced ROS1 -Positive Non−Small Cell Lung Cancer
1个月前
已完结
Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancer
1个月前
已完结
Favorable treatment response of bevacizumab-combined chemotherapy for advanced or recurrent invasive mucinous adenocarcinoma of the lung: A retrospective observational study
1个月前
已完结
Genomic Landscape of Resected Invasive Mucinous Adenocarcinoma of the Lung
1个月前
已完结
Invasive mucinous adenocarcinoma of the lung: clinicopathological features, 18F-FDG PET/CT findings, and survival outcomes
1个月前
已完结
皖公网安备34019202002308
